The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) mice

Sara E Meyer1, Susan E Waltz, Kathleen H Goss

  • 1Department of Cancer and Cell Biology, University of Cincinnati, Cincinnati, Ohio, USA.

Insights

Ron receptor tyrosine kinase may play a role in normal intestinal homeostasis. However, its absence did not affect tumor growth in Apc-mutant mice, suggesting Ron is not required for adenoma formation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • The Ron receptor tyrosine kinase is frequently overexpressed in human colon cancers, correlating with tumor progression.
  • Loss of the adenomatous polyposis coli (APC) tumor suppressor is an early event in most colon tumors, leading to beta-catenin stabilization.

Purpose of the Study:

  • To investigate the role of Ron signaling in early-stage intestinal tumorigenesis.
  • To determine if Ron is necessary for the development and growth of Apc-mutant adenomas.

Main Methods:

  • Generation of Apc-mutant (Apc(Min/+)) mice with and without functional Ron signaling.
  • Comparison of tumor burden, crypt proliferation, tumor histology, and beta-catenin localization between groups.

Main Results:

  • Apc(Min/+) mice lacking Ron signaling exhibited a significantly higher tumor burden compared to Apc(Min/+) mice with wild-type Ron.
  • Increased intestinal crypt proliferation was observed in Apc(Min/+) Ron-deficient mice.
  • Loss of Ron did not alter tumor size, histological appearance, or beta-catenin localization in Apc(Min/+) adenomas.

Conclusions:

  • Ron signaling may be involved in maintaining normal intestinal tissue homeostasis.
  • Ron expression is not essential for the initiation or progression of adenomas in the Apc(Min/+) mouse model of intestinal tumorigenesis.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...